| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |